Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of 0.25% Desoximetasone cream
(Topoxy®) compare with 0.25% Desoximetasone cream (Topicorte®) in the treatment of scalp
psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Siriraj Hospital
Collaborators:
Siriraj clinical research center SPS MEDICAL CO.,LTD.